Daily FNArena News - Australia

If market rumours are correct, small cap Arasor is about to become a lot bigger. Today’s share price is already up by 12%.

A fall in imports helped slice Australia’s trade deficit in November, but ANZ suggests the drought may reverse the improvements made last year in our terms of trade.

Peptech is likely to use the sale proceeds from its Domantis asset to acquire additional antibody technologies, which Intersuisse suggests justifies a Speculative Buy rating.

November retail sales were slightly below market expectations, but strong enough to suggest Australia’s economy remains on a solid footing.

The latest update on Australia’s retail sales by the ABS has generated another estimated 0.4% growth for November last year. It would appear that Canberra in particular is doing well.

ABN Amro has initiated coverage on Mortgage Choice with a Buy rating based on forecast solid earnings growth and an attractive dividend yield.

While housing data for November was slightly stronger than expected the three interest rate increases last year continue to impact on the health of the market.

The trend seems to have reversed for major newspapers, but the same applies to the internet, ANZ believes.

ABN Amro Morgans believes Avexa shares should be a good way to start the new year with the share price expected to rise strongly between now and March.

Harold Mitchell’s master plan of a large, fully encompassing advertisement giant across the Tasman is likely to transform emitch beyond recognition. Short term share price weakness should be a given.